Cardlytics (NASDAQ:CDLX) CFO David Thomas Evans Purchases 50,000 Shares

Cardlytics, Inc. (NASDAQ:CDLX) CFO David Thomas Evans purchased 50,000 shares of the stock in a transaction that occurred on Monday, May 18th. The stock was purchased at an average price of $0.63 per share, with a total value of $31,500.00. Following the acquisition, the chief financial officer directly owned 317,930 shares of the company’s stock, valued at $200,295.90. This trade represents a 18.66% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

David Thomas Evans also recently made the following trade(s):

• On Friday, May 15th, David Thomas Evans acquired 150,000 shares of Cardlytics stock. The shares were purchased at an average price of $0.65 per share, for a total transaction of $97,500.00.

Cardlytics Stock Down 1.6%

Shares of NASDAQ CDLX opened at $0.60 on Wednesday. Cardlytics, Inc. has a twelve month low of $0.57 and a twelve month high of $3.28. The firm has a market cap of $34.34 million, a PE ratio of -0.34 and a beta of 0.67. The business has a fifty day simple moving average of $0.87 and a two-hundred day simple moving average of $1.05.

Cardlytics (NASDAQ:CDLX) last posted its quarterly earnings results on Wednesday, March 4th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.08). The firm had revenue of $56.10 million for the quarter, compared to the consensus estimate of $54.46 million. Cardlytics had a negative return on equity of 956.56% and a negative net margin of 46.03%. On average, research analysts expect that Cardlytics, Inc. will post -0.11 earnings per share for the current year.

Analyst Upgrades and Downgrades

CDLX has been the subject of several recent research reports. Lake Street Capital set a $1.00 price target on shares of Cardlytics in a report on Friday, May 8th. Wall Street Zen raised shares of Cardlytics from a “sell” rating to a “hold” rating in a report on Saturday, April 4th. Evercore set a $1.00 price objective on shares of Cardlytics in a research note on Friday, March 6th. Bank of America restated an “underperform” rating on shares of Cardlytics in a report on Thursday, March 5th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Cardlytics in a report on Friday, April 10th. One analyst has rated the stock with a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Sell” and a consensus target price of $1.00.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. Bank of America Corp DE lifted its position in Cardlytics by 262.7% during the third quarter. Bank of America Corp DE now owns 1,632,786 shares of the company’s stock valued at $3,968,000 after acquiring an additional 1,182,593 shares during the last quarter. Quinn Opportunity Partners LLC grew its holdings in Cardlytics by 900.0% in the third quarter. Quinn Opportunity Partners LLC now owns 1,100,000 shares of the company’s stock worth $2,673,000 after purchasing an additional 990,000 shares during the last quarter. UBS Group AG increased its position in shares of Cardlytics by 112.5% during the third quarter. UBS Group AG now owns 458,066 shares of the company’s stock worth $1,113,000 after purchasing an additional 242,536 shares in the last quarter. Raymond James Financial Inc. lifted its holdings in shares of Cardlytics by 36,915.3% during the 3rd quarter. Raymond James Financial Inc. now owns 133,255 shares of the company’s stock valued at $324,000 after purchasing an additional 132,895 shares during the last quarter. Finally, Jane Street Group LLC lifted its holdings in shares of Cardlytics by 263.0% during the 2nd quarter. Jane Street Group LLC now owns 162,427 shares of the company’s stock valued at $267,000 after purchasing an additional 117,687 shares during the last quarter. Hedge funds and other institutional investors own 68.10% of the company’s stock.

Cardlytics Company Profile

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.